JIANGSU YAHONG MEDITECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.38 CNY | +1.59% |
|
-0.78% | -40.82% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jiangsu Yahong Meditech Co Ltd is a China-based company mainly engaged in drug research and development (R&D). The Company focuses on innovative drugs in the field of urogenital tumors and other major diseases. The product pipelines being developed by the Company include APL-1202, APL-1501, APL-1706, APL-1702, ASN-1764, ASN-1780, APL-1901, APL-1401, ASN-1733 and others. The Company is still in the R&D stage.
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.38
CNY
Average target price
12.28
CNY
Spread / Average Target
+92.55%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -40.82% | 504M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -2.53% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
- Stock Market
- Equities
- 688176 Stock
- News Jiangsu Yahong Meditech Co., Ltd.
- Jiangsu Yahong Meditech Completes Phase III Trial Into APL1702 Drug; Shares Drop 4%
